Mr. James Parsons reports
Trillium Therapeutics To Present At Investor Conference
Trillium Therapeutics Inc. is scheduled to present at the following upcoming investor conference.
H.C. Wainwright 21st Annual Global Investment Conference
Presenter: Dr. Bob Uger, chief scientific officer and interim president
Date and time: Sept. 10, 2019, at 4:40 p.m. ET
Location: Lotte New York Palace Hotel, New York
A live audio webcast of the H.C. Wainwright 21st Annual Global Investment Conference presentation will be available under the investor relations section of Trillium's website.
About Trillium Therapeutics Inc.
Trillium is an immuno-oncology company developing innovative therapies for the treatment of cancer.
© 2020 Canjex Publishing Ltd. All rights reserved.